Shanghai Bendao Gene Technology
PrivateLast Round
Strategic
Apr 2, 2026
Total Funding Raised
$66.9M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Shanghai Bendao Gene Technology operates in Healthcare & Life Sciences and is based in Shanghai. Its latest recorded funding round was a Strategic round in April 2026.
Shanghai Bendao Gene Technology is a biotechnology company that develops gene therapies for major diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Shanghai Bendao Gene Technology Comparables
Compare Shanghai Bendao Gene Technology with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| HuidaGene Therapeutics | 87% | |
| EdiGene | 84% | |
| Excision BioTherapeutics | 83% |
For institutional investors. Book with your work email.
Shanghai Bendao Gene Technology Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Strategic | Apr 2, 2026 | ||||
| Series B | Jun 27, 2023 | ||||
| Series A | Apr 13, 2021 | ||||
| Early Funding | Mar 1, 2020 | ||||
| Strategic | Jun 26, 2019 |
For institutional investors. Book with your work email.
Shanghai Bendao Gene Technology Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Sunland Fund | Series B |
| Emerging Technology Partners | Series A |
| Longmen Capital | Series A |
| Hermed Capital | Series B |
| Tsinghua Holdings Capital | Series A |
| Keytone Ventures | Early Funding |
| Inno Angel Fund | Series A |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 24, 2026
Monthly visitors increased 34% MoM, reaching 2.5K.
- Jun 17, 2026
Monthly visitors grew 83% MoM.
For institutional investors. Book with your work email.
Shanghai Bendao Gene Technology Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Shanghai Bendao Gene Technology's valuation, stock price, and market status.
Is Shanghai Bendao Gene Technology a public or private company?
Shanghai Bendao Gene Technology is a private company.
What is the current stock price of Shanghai Bendao Gene Technology?
Shanghai Bendao Gene Technology is a private company, so its shares have no public market price. Caplight tracks Shanghai Bendao Gene Technology's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Shanghai Bendao Gene Technology worth (valuation)?
Valuation information for Shanghai Bendao Gene Technology is not publicly available.
Can I buy Shanghai Bendao Gene Technology stock?
Shanghai Bendao Gene Technology shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Shanghai Bendao Gene Technology's last funding round?
Shanghai Bendao Gene Technology's most recent funding round was Strategic on April 2, 2026.
Who are the main investors in Shanghai Bendao Gene Technology?
Key investors in Shanghai Bendao Gene Technology include Tsinghua Holdings Capital, Keytone Ventures, Efung Capital.
Will Shanghai Bendao Gene Technology IPO soon?
No public IPO plans have been announced for Shanghai Bendao Gene Technology.
How can I track Shanghai Bendao Gene Technology secondary market activity?
Caplight tracks bids, offers, and trades in Shanghai Bendao Gene Technology's shares on secondary markets.